United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 2740,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "5cc63779-8ae2-4877-b8b0-1a59f47eeebc",
"title": "Elastic N.V. (ESTC) Reports Strong Q4, Highlights New AWS Collaboration",
"description": "Key Takeaways:\n Elastic N.V. (ESTC) achieves significant revenue growth driven by its cloud services. Analysts project a potential 38.52% stock price incr",
"keywords": "GuruFocus, Article, News, GuruFocus News, ESTC",
"snippet": "Key Takeaways:\n\nElastic N.V. (ESTC, Financial) achieves significant revenue growth driven by its cloud services.\n\nAnalysts project a potential 38.52% stock pric...",
"url": "https://www.gurufocus.com/news/2897568/elastic-nv-estc-reports-strong-q4-highlights-new-aws-collaboration",
"image_url": "https://static.gurufocus.com/logos/0C0000BIPX.png?20",
"language": "en",
"published_at": "2025-05-30T03:55:18.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ESTC",
"name": "Elastic N.V.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 100.219666,
"sentiment_score": 0.589743,
"highlights": [
{
"highlight": "Key Takeaways:\n\n<em>Elastic</em> <em>N.V[+332 characters]",
"sentiment": 0.8689,
"highlighted_in": "main_text"
},
{
"highlight": "(ESTC) reported a robust 16% revenue inc[+295 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts' Projections\n\nAccor[+301 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Explore more detailed forecast data on t[+256 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "GuruFocus Fair Value Estimate\n\n<em>Elast[+310 characters]",
"sentiment": 0.9493,
"highlighted_in": "main_text"
},
{
"highlight": "Comprehensive data is available on the <[+231 characters]",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Elastic</em> <em>N.V</em>. (ESTC) Reports Strong Q4, Highlights New AWS Collaboration",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "385b8829-d3ad-49d7-afb3-37ca7ce4bc82",
"title": "UiPath Inc (PATH) Reports Strong Q1 Fiscal 2026 Results with New Product Launches | PATH stock news",
"description": "Summary UiPath Inc (PATH), a leader in agentic automation, announced its financial results for the first quarter of fiscal 2026, ending April 30, 2025. The comp",
"keywords": "GuruFocus, Article, News, GuruFocus News, PATH",
"snippet": "Summary\n\nUiPath Inc (PATH, Financial), a leader in agentic automation, announced its financial results for the first quarter of fiscal 2026, ending April 30, 20...",
"url": "https://www.gurufocus.com/news/2897194/uipath-inc-path-reports-strong-q1-fiscal-2026-results-with-new-product-launches-path-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-29T22:11:07.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PATH",
"name": "UiPath Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 101.541,
"sentiment_score": 0.21118,
"highlights": [
{
"highlight": "Summary\n\n<em>UiPath</em> <em>Inc</em> (<[+298 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Launch of the agentic automation platfor[+300 characters]",
"sentiment": -0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "A: <em>UiPath</em> reported a revenue of[+317 characters]",
"sentiment": 0.644,
"highlighted_in": "main_text"
},
{
"highlight": "A: <em>UiPath</em> expects revenue betwe[+315 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UiPath</em> <em>Inc</em> (<em>PATH</em>) Reports Strong Q1 Fiscal 2026 Results with New Product Launches | <em>PATH</em> stock news",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
},
{
"symbol": "P2AT34.SA",
"name": "UiPath Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 70.582726,
"sentiment_score": 0.21118,
"highlights": [
{
"highlight": "Summary\n\n<em>UiPath</em> <em>Inc</em> (P[+289 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Launch of the agentic automation platfor[+300 characters]",
"sentiment": -0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "A: <em>UiPath</em> reported a revenue of[+317 characters]",
"sentiment": 0.644,
"highlighted_in": "main_text"
},
{
"highlight": "A: <em>UiPath</em> expects revenue betwe[+315 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UiPath</em> <em>Inc</em> (PATH) Reports Strong Q1 Fiscal 2026 Results with New Product Launches | PATH stock news",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "2e2538c4-d34c-4499-9a0b-3b8e9e7283f5",
"title": "Elastic (ESTC) Beats Q4 Expectations, Provides Strong Fiscal 2026 Outlook",
"description": "Key Highlights:\n Elastic (NYSE: ESTC) surpasses earnings expectations with a strong Q4 performance. Analysts project substantial upside potential, with pr",
"keywords": "GuruFocus, Article, News, GuruFocus News, ESTC",
"snippet": "Key Highlights:\n\nElastic (NYSE: ESTC) surpasses earnings expectations with a strong Q4 performance.\n\nAnalysts project substantial upside potential, with price t...",
"url": "https://www.gurufocus.com/news/2896992/elastic-estc-beats-q4-expectations-provides-strong-fiscal-2026-outlook",
"image_url": "https://static.gurufocus.com/logos/0C0000BIPX.png?20",
"language": "en",
"published_at": "2025-05-29T21:59:49.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ESTC",
"name": "Elastic N.V.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 58.64816,
"sentiment_score": 0.612743,
"highlights": [
{
"highlight": "Key Highlights:\n\n<em>Elastic</em> (<em>N[+263 characters]",
"sentiment": 0.8689,
"highlighted_in": "main_text"
},
{
"highlight": "Elastic's Robust Q4 Performance\n\n<em>Ela[+301 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Looking forward, <em>Elastic</em> antici[+281 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "Investors seeking more detailed projecti[+280 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "Estimating Elastic's GF Value\n\nAccording[+223 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "For a comprehensive analysis, the <em>El[+58 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Elastic</em> (ESTC) Beats Q4 Expectations, Provides Strong Fiscal 2026 Outlook",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "bc4b3003-9e54-4fb8-b1f7-6163c1925de3",
"title": "Riley Stock Takes Advantage Of Low Valuations To Build Asset Base (NYSE:REPX)",
"description": "Riley Exploration Permian (REPX) offers strong growth potential with strategic acquisitions, a 5.7% dividend yield, low breakeven costs, & compelling valuation. See more.",
"keywords": "",
"snippet": "Riley Exploration Permian (NYSE: REPX ) is a Permian pure player, with a 60-40 oil-gas split for production. Across 78,600 acres, and a planned acquisition of a...",
"url": "https://seekingalpha.com/article/4791080-riley-takes-advantage-of-low-valuations-to-build-asset-base",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1745180643/image_1745180643.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-30T03:37:42.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "REPX",
"name": "Riley Exploration Permian, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 44.938347,
"sentiment_score": 0.4755,
"highlights": [
{
"highlight": "<em>Riley</em> <em>Exploration</em> <em>[+343 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Analyst’s Disclosure: I/we have a bene[+308 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "HAL",
"name": "Halliburton Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 16.271152,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "Benjamin <em>Halliburton</em>, our found[+305 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "edb8c51f-c435-48cf-9512-75209b518d4a",
"title": "Electronic Materials Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period",
"description": "The electronics materials market was valued at USD 62.1 billion globally in 2024 and is expected to expand at a rate of 5.9% over the course of the forecast period. Market expansion is being…",
"keywords": "",
"snippet": "Electronic Materials Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period Neha Singh Follow 3 m...",
"url": "https://medium.com/@ns1996658/the-electronics-materials-market-was-valued-at-usd-62-1-1eaa6272fb08",
"image_url": "https://miro.medium.com/v2/resize:fit:550/1*3jXkSBQ9v4xyOp1R9NJLIw.jpeg",
"language": "en",
"published_at": "2025-05-30T03:31:01.000000Z",
"source": "medium.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALB",
"name": "Albemarle Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 22.706501,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Laminates\n\n· Specialty gases\n\n· Wet ch[+351 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Corporation</em>\n\n· Cabot Corporati[+39 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CBT",
"name": "Cabot Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 21.766237,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Wet chemicals and solvents\n\n· Photoresi[+339 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Corporation</em>\n\n· Monsanto Electr[+17 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LIN",
"name": "Linde plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 22.592436,
"sentiment_score": 0.8074,
"highlights": [
{
"highlight": "· <em>Linde</em> <em>Plc</em>\n\n· Reson[+321 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "71397603-37c3-4161-802f-4db0e952fe8b",
"title": "Keros Therapeutics, Inc. (KROS) Halts PAH Drug Development After Safety Concerns in TROPOS Trial",
"description": "Keros Therapeutics, Inc.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/keros-therapeutics-inc-kros-halts-pah-drug-development-after-safety-concerns-in-tropos-trial-1543967/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/10/14205200/KROS-insidermonkey-1697331117515.jpg",
"language": "en",
"published_at": "2025-05-30T03:24:02.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "KROS",
"name": "Keros Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 127.98421,
"sentiment_score": 0.4215,
"highlights": [
{
"highlight": "<em>Keros</em> <em>Therapeutics</em>, <em>Inc</em>. (KROS) Halts PAH Drug Development After Safety Concerns in TROPOS Trial",
"sentiment": 0.4215,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "3015be9c-b0de-499c-a6e3-06340f1eb3a1",
"title": "Lantern Pharma Inc. (LTRN)’s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models",
"description": "Lantern Pharma Inc.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/lantern-pharma-inc-ltrns-lp-184-shows-345-survival-gain-in-rare-pediatric-brain-tumor-models-1543974/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/12/12100508/ANVS-insidermonkey-1702393506802.jpg",
"language": "en",
"published_at": "2025-05-30T03:21:17.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "LTRN",
"name": "Lantern Pharma Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 112.757126,
"sentiment_score": 0.2023,
"highlights": [
{
"highlight": "<em>Lantern</em> <em>Pharma</em> <em>Inc</em>. (LTRN)’s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models",
"sentiment": 0.2023,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "4060f677-e89f-492d-9377-b268613bacbf",
"title": "Comstock Resources' Share Price Attributes A High Value To The Western Haynesville (CRK)",
"description": "Comstock's strong Freestone well boosts projections. Read here for CRK stock's key insights on valuation, cash burn, and natural gas prices.",
"keywords": "",
"snippet": "We are currently offering a free two-week trial to Distressed Value Investing . Join our community to receive exclusive research about various companies and oth...",
"url": "https://seekingalpha.com/article/4791077-comstock-resources-current-share-price-attributes-a-high-value-to-the-western-haynesville-reiterate-sell",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1745180643/image_1745180643.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-30T03:19:31.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "CRK",
"name": "Comstock Resources, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 78.66804,
"sentiment_score": 0.2787,
"highlights": [
{
"highlight": "<em>Comstock</em> <em>Resources</em> (<e[+113 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Comstock</em> <em>Resources</em>' Share Price Attributes A High Value To The Western Haynesville (CRK)",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "e458d802-1403-47ec-8703-adc95a52e319",
"title": "Abercrombie & Fitch Stock: Value Buy At Current Levels (NYSE:ANF)",
"description": "Abercrombie & Fitch faces macroeconomic risks, inflation, and tariff issues. Macro stabilization could present a long-term opportunity. See more on ANF stock here.",
"keywords": "",
"snippet": "Abercrombie & Fitch Co. (NYSE: ANF ) is at the crossroads. A fall from a peak of ~62% has cushioned downsides. But macroeconomic pressures exist. To start, the ...",
"url": "https://seekingalpha.com/article/4791076-abercrombie-and-fitch-value-buy-at-current-levels",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1450819400/image_1450819400.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-30T03:18:41.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "ANF",
"name": "Abercrombie & Fitch Co.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 152.92558,
"sentiment_score": 0.0109,
"highlights": [
{
"highlight": "<em>Abercrombie</em> & <em>Fitch</em> <e[+212 characters]",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Abercrombie</em> & <em>Fitch</em> Stock: Value Buy At Current Levels (<em>NYSE:ANF</em>)",
"sentiment": 0.34,
"highlighted_in": "title"
}
]
},
{
"symbol": "BCS",
"name": "Barclays PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 13.105297,
"sentiment_score": -0.0258,
"highlights": [
{
"highlight": "As a former Vice President at <em>Barcla[+317 characters]",
"sentiment": -0.0258,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "f3f5043b-f42b-49a8-bd6d-349e3ec57feb",
"title": "Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests",
"description": "Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the development and commercialization of advanced diagnostic tools aimed at expanding precision...",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/danaher-corporation-dhr-launches-partnership-with-astrazeneca-plc-azn-to-scale-next-gen-precision-medicine-tests-1543929/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/12/01183920/NML-insidermonkey-1701473958399.jpg",
"language": "en",
"published_at": "2025-05-30T03:11:52.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "AZN",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 70.11142,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Danaher Corporation (DHR) Launches Partnership with <em>AstraZeneca</em> <em>PLC</em> (AZN) to Scale Next-Gen Precision Medicine Tests",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "DHR",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 77.117836,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Danaher</em> <em>Corporation</em> (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "a78c2d78-6019-4020-9512-bf1d9c267624",
"title": "Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
"description": "PR NewswireWASHINGTON, May 29, 2025\n\n\n\nDanaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generatio",
"keywords": "GuruFocus, Article, News, PRNewswire, LSE:AZN, NAS:AZN, NYSE:DHR, OSTO:AZN",
"snippet": "Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics\n\nThis partner...",
"url": "https://www.gurufocus.com/news/2897124/danaher-announces-diagnostic-development-and-commercialization-partnership-to-scale-precision-medicine",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-29T22:00:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DHR",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.570763,
"sentiment_score": 0.44845,
"highlights": [
{
"highlight": "<em>Danaher</em> has entered a partnersh[+334 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "of the development cycle across diagnost[+361 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "\"Precision medicines are more targeted t[+191 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "This partnership will utilize the newly [+275 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "\"Our partnership with <em>Danaher</em> a[+197 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "ABOUT <em>DANAHER</em>\n\n<em>Danaher</em>[+285 characters]",
"sentiment": 0.8155,
"highlighted_in": "main_text"
},
{
"highlight": "Focused on scientific excellence, innova[+277 characters]",
"sentiment": 0.9607,
"highlighted_in": "main_text"
},
{
"highlight": "FORWARD-LOOKING STATEMENTS\n\nStatements i[+318 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "View original content:https://www.prnews[+195 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Danaher</em> Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "DAP.DE",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.48175,
"sentiment_score": 0.44845,
"highlights": [
{
"highlight": "<em>Danaher</em> has entered a partnersh[+334 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "of the development cycle across diagnost[+343 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "\"Precision medicines are more targeted t[+191 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "This partnership will utilize the newly [+275 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "\"Our partnership with <em>Danaher</em> a[+197 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "ABOUT <em>DANAHER</em>\n\n<em>Danaher</em>[+285 characters]",
"sentiment": 0.8155,
"highlighted_in": "main_text"
},
{
"highlight": "Focused on scientific excellence, innova[+277 characters]",
"sentiment": 0.9607,
"highlighted_in": "main_text"
},
{
"highlight": "FORWARD-LOOKING STATEMENTS\n\nStatements i[+318 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "View original content:https://www.prnews[+195 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Danaher</em> Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "AZN",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.14075,
"sentiment_score": 0.64576,
"highlights": [
{
"highlight": "Danaher has entered a partnership with <[+325 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "of the development cycle across diagnost[+343 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "\"We are excited to work with <em>AstraZe[+297 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "\"The transformative potential of next-wa[+238 characters]",
"sentiment": 0.6801,
"highlighted_in": "main_text"
},
{
"highlight": "\"With our global footprint and leading d[+233 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DHR.MX",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.468212,
"sentiment_score": 0.44845,
"highlights": [
{
"highlight": "<em>Danaher</em> has entered a partnersh[+334 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "of the development cycle across diagnost[+343 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "\"Precision medicines are more targeted t[+191 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "This partnership will utilize the newly [+275 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "\"Our partnership with <em>Danaher</em> a[+197 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "ABOUT <em>DANAHER</em>\n\n<em>Danaher</em>[+285 characters]",
"sentiment": 0.8155,
"highlighted_in": "main_text"
},
{
"highlight": "Focused on scientific excellence, innova[+277 characters]",
"sentiment": 0.9607,
"highlighted_in": "main_text"
},
{
"highlight": "FORWARD-LOOKING STATEMENTS\n\nStatements i[+318 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "View original content:https://www.prnews[+195 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Danaher</em> Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "AZN.L",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "Healthcare",
"match_score": 16.477856,
"sentiment_score": 0.64576,
"highlights": [
{
"highlight": "Danaher has entered a partnership with <[+325 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "of the development cycle across diagnost[+325 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "\"We are excited to work with <em>AstraZe[+297 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "\"The transformative potential of next-wa[+238 characters]",
"sentiment": 0.6801,
"highlighted_in": "main_text"
},
{
"highlight": "\"With our global footprint and leading d[+233 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0A4J.L",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 16.477654,
"sentiment_score": 0.64576,
"highlights": [
{
"highlight": "Danaher has entered a partnership with <[+325 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "of the development cycle across diagnost[+325 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "\"We are excited to work with <em>AstraZe[+297 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "\"The transformative potential of next-wa[+238 characters]",
"sentiment": 0.6801,
"highlighted_in": "main_text"
},
{
"highlight": "\"With our global footprint and leading d[+233 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2B.L",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 52.400555,
"sentiment_score": 0.44845,
"highlights": [
{
"highlight": "<em>Danaher</em> has entered a partnersh[+334 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "of the development cycle across diagnost[+343 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "\"Precision medicines are more targeted t[+191 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "This partnership will utilize the newly [+275 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "\"Our partnership with <em>Danaher</em> a[+197 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "ABOUT <em>DANAHER</em>\n\n<em>Danaher</em>[+285 characters]",
"sentiment": 0.8155,
"highlighted_in": "main_text"
},
{
"highlight": "Focused on scientific excellence, innova[+277 characters]",
"sentiment": 0.9607,
"highlighted_in": "main_text"
},
{
"highlight": "FORWARD-LOOKING STATEMENTS\n\nStatements i[+318 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "View original content:https://www.prnews[+195 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Danaher</em> Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "DHER34.SA",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.45379,
"sentiment_score": 0.44845,
"highlights": [
{
"highlight": "<em>Danaher</em> has entered a partnersh[+334 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "of the development cycle across diagnost[+343 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "\"Precision medicines are more targeted t[+191 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "This partnership will utilize the newly [+275 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "\"Our partnership with <em>Danaher</em> a[+197 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "ABOUT <em>DANAHER</em>\n\n<em>Danaher</em>[+285 characters]",
"sentiment": 0.8155,
"highlighted_in": "main_text"
},
{
"highlight": "Focused on scientific excellence, innova[+277 characters]",
"sentiment": 0.9607,
"highlighted_in": "main_text"
},
{
"highlight": "FORWARD-LOOKING STATEMENTS\n\nStatements i[+318 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "View original content:https://www.prnews[+195 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Danaher</em> Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "a0690029-5c19-4cab-821d-87256871269b",
"title": "PagerDuty, Inc. (PD) Q1 2026 Earnings Call Transcript",
"description": "PagerDuty, Inc. (NYSE:PD) Q1 2026 Earnings Conference Call May 29, 2025 5:00 PM ETCompany ParticipantsTony Righetti - Vice President of Investor...",
"keywords": "",
"snippet": "PagerDuty, Inc. (NYSE:PD) Q1 2026 Earnings Conference Call May 29, 2025 5:00 PM ET\n\nCompany Participants\n\nTony Righetti - Vice President of Investor Relations\n\n...",
"url": "https://seekingalpha.com/article/4791087-pagerduty-inc-pd-q1-2026-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2025-05-30T03:07:33.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "PD",
"name": "PagerDuty, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 114.40695,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>PagerDuty</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NYSE:PD</em>) Q1 2026 Earnings Conf[+323 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PagerDuty</em>, <em>Inc</em>. (PD) Q1 2026 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "7eab9ea8-baf7-459b-af0e-8497be84ab2e",
"title": "UiPath Inc. (PATH) Q1 2026 Earnings Call Transcript",
"description": "UiPath Inc. (NYSE:PATH) Q1 2026 Earnings Conference Call May 29, 2025 5:00 PM ETCompany ParticipantsAllise Furlani - VP of IRDaniel Dines - Founder and...",
"keywords": "",
"snippet": "UiPath Inc. (NYSE:PATH) Q1 2026 Earnings Conference Call May 29, 2025 5:00 PM ET\n\nCompany Participants\n\nAllise Furlani - VP of IR\n\nDaniel Dines - Founder and CE...",
"url": "https://seekingalpha.com/article/4791058-uipath-inc-path-q1-2026-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2025-05-30T00:00:36.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "PATH",
"name": "UiPath Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 134.3028,
"sentiment_score": 0.31445,
"highlights": [
{
"highlight": "<em>UiPath</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NYSE:PATH</em>) Q1 2026 Earnings Co[+323 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Alex Zukin - Wolfe Research\n\nNick Altman[+117 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "Allise Furlani\n\nGood afternoon, and than[+190 characters]",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Our earnings release and financial suppl[+208 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UiPath</em> <em>Inc</em>. (<em>PATH</em>) Q1 2026 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "P2AT34.SA",
"name": "UiPath Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 91.75354,
"sentiment_score": 0.30156,
"highlights": [
{
"highlight": "<em>UiPath</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Furlani - VP of IR\n\nDaniel Dines - Found[+329 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "Allise Furlani\n\nGood afternoon, and than[+190 characters]",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Our earnings release and financial suppl[+208 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UiPath</em> <em>Inc</em>. (PATH) Q1 2026 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "bd0c1cd0-cf58-43a7-9805-6ea418491846",
"title": "Marvell Technology, Inc. (MRVL) Q1 2026 Earnings Call Transcript",
"description": "Call Start: 16:45 Call End: 17:36 March 1, 0000 ETQ1 2026 Earnings Conference CallMay 29, 2025, 4:45 PM ETCompany ParticipantsAshish Saran - Senior Vice...",
"keywords": "",
"snippet": "Call Start: 16:45 Call End: 17:36 March 1, 0000 ET\n\nQ1 2026 Earnings Conference Call\n\nMay 29, 2025, 4:45 PM ET\n\nCompany Participants\n\nAshish Saran - Senior Vice...",
"url": "https://seekingalpha.com/article/4791050-marvell-technology-inc-mrvl-q1-2026-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2025-05-29T23:27:39.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRVL",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 133.40988,
"sentiment_score": 0.152933,
"highlights": [
{
"highlight": "America\n\nRoss Seymore - Deutsche Bank\n\nT[+331 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Technology</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Marvell</em> <em>Technology</em>, <em>Inc</em>. (MRVL) Q1 2026 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRVL1.MX",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 133.40741,
"sentiment_score": 0.152933,
"highlights": [
{
"highlight": "America\n\nRoss Seymore - Deutsche Bank\n\nT[+331 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Technology</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Marvell</em> <em>Technology</em>, <em>Inc</em>. (MRVL) Q1 2026 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0UBI.L",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 133.40166,
"sentiment_score": 0.152933,
"highlights": [
{
"highlight": "America\n\nRoss Seymore - Deutsche Bank\n\nT[+331 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Technology</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Marvell</em> <em>Technology</em>, <em>Inc</em>. (MRVL) Q1 2026 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "db71fd93-bd63-4acc-b602-f62bc1295a8a",
"title": "XXRP ETF: Volatility On Top Of Volatility (NYSEARCA:XXRP)",
"description": "Gain leveraged XRP exposure in the US with Teucrium 2x Long Daily XRP ETF (XXRP). Read here for an in-depth investment analysis of XXRP ETF.",
"keywords": "",
"snippet": "In my recent coverage of the Bitwise 10 Crypto Index Fund ETF ( OTC:BITW ) for Seeking Alpha, I made note of how it was becoming increasingly possible to mimic ...",
"url": "https://seekingalpha.com/article/4791075-xxrp-volatility-on-top-of-volatility",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1135927483/image_1135927483.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-30T03:04:29.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "BITW",
"name": "Bitwise 10 Crypto Index Fund",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 81.94852,
"sentiment_score": 0.1027,
"highlights": [
{
"highlight": "In my recent coverage of the <em>Bitwise[+340 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "f9526ccf-b155-4622-b891-0edb4ee23014",
"title": "Alerian MLP ETF Tax Update",
"description": "Alerian MLP ETF (the ”Fund” or ”AMLP”) has modified the estimate of the Fund's deferred tax liability based on information reported by the Master Limit",
"keywords": "GuruFocus, Article, News, Business Wire, NAS:SSNC",
"snippet": "Alerian MLP ETF (the “Fund” or “AMLP”) has modified the estimate of the Fund’s deferred tax liability based on information reported by the Master Limi...",
"url": "https://www.gurufocus.com/news/2897552/alerian-mlp-etf-tax-update",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T03:00:01.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMLP",
"name": "Alerian MLP ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 240.1568,
"sentiment_score": 0.204733,
"highlights": [
{
"highlight": "<em>Alerian</em> <em>MLP</em> <em>ETF</e[+333 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "All K-1s are received and processed by t[+305 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Alerian</em> <em>MLP</em> <em>ETF</em> Tax Update",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "ENFR",
"name": "Alerian Energy Infrastructure ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 28.265968,
"sentiment_score": 0.6249,
"highlights": [
{
"highlight": "ALPS Portfolio Solutions Distributor, In[+238 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "2fc7429d-c3c0-400c-82b3-6ba735537c31",
"title": "First Trust Advisors L.P. Announces Distribution for First Trust Enhanced Short Maturity ETF",
"description": "First Trust Advisors L.P. (\"FTA\") announces the declaration of the Monthly distribution for First Trust Enhanced Short Maturity ETF, a series of First Trust Ex",
"keywords": "GuruFocus, Article, News, Business Wire, NAS:FTSM",
"snippet": "First Trust Advisors L.P. (\"FTA\") announces the declaration of the Monthly distribution for First Trust Enhanced Short Maturity ETF, a series of First Trust Exc...",
"url": "https://www.gurufocus.com/news/2897050/first-trust-advisors-lp-announces-distribution-for-first-trust-enhanced-short-maturity-etf",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-29T22:00:09.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "FTSM",
"name": "First Trust Enhanced Short Maturity ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 268.67358,
"sentiment_score": 0.4601,
"highlights": [
{
"highlight": "(\"FTA\") announces the declaration of the[+169 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "The following dates apply to today's dis[+357 characters]",
"sentiment": 0.8192,
"highlighted_in": "main_text"
},
{
"highlight": "<em>ETF</em> Monthly $0.2275\n\nFirst Trus[+15 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Announces Distribution for <em>First</em> <em>Trust</em> <em>Enhanced</em> <em>Short</em> <em>Maturity</em> <em>ETF</em>",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 3879,
"sentiment_avg": 0.2987734556607119
}
]
}
Other details
Entity count
- 32,649